CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

Clinical and Laboratory Standards Institute, 02/01/2008

Publisher: CLSI

File Format: PDF

$108.00$216.21

Description

Published:01/02/2008

Pages:44

Clinical and Laboratory Standards Institute document I/LA30-A—Immunoassay Interference by Endogenous Antibodies; Approved Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

More CLSI standard pdf

CLSI M51-A (R2018)

Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Approved Guideline, M51A

$90.00 $180.00

CLSI GP44-A4 (R2018)

Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests; Approved Guideline-Fourth Edition, GP44A4E

$90.00 $180.00

CLSI EP22-P

Presentation of a Manufacturer's Risk Mitigation Information for Users of In Vitro Diagnostic Devices; Proposed Guideline, EP22PE

$140.00 $281.60

CLSI M100-S20

Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, M100S20

$127.00 $254.75